MedPath

The effect of intravitreal ranibizumab on systemic hypertension in age-related macular degeneration patients with hypertension.

Not Applicable
Recruiting
Conditions
age-related macular degeneration
Registration Number
JPRN-UMIN000013240
Lead Sponsor
Institute of Health Biosciences, The University of Tokushima Graduate School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Patients refused entry into the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath